≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified mononeuropathies of upper limb

DOID EFO Endpoint Browser PheWeb

G6_MONONPOTHUS

mononeuropathy: Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ischemia; traumatic injury; compression; connective tissue diseases; cumulative trauma disorders; and other conditions.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G56.8, G56.9
  • Hospital discharge: ICD-9 — 354[8-9]
  • Cause of death: ICD-10 — G56.8, G56.9
  • Cause of death: ICD-9 — 354[8-9]

2 out of 7 registries used, show all original rules.

1154

4. Check minimum number of events

None

1154

5. Include endpoints

None

1154

6. Filter based on genotype QC (FinnGen only)

1154

Control definitions (FinnGen only)

Control exclude
G6_NERPLEX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8274 4003 4241
Only index persons 7776 3828 3948
Unadjusted period prevalence (%)
Whole population 0.12 0.11 0.12
Only index persons 0.15 0.14 0.15
Median age at first event (years)
Whole population 47.79 49.30 46.34
Only index persons 47.14 48.74 45.59

-FinnGen-

Key figures

All Female Male
Number of individuals 1154 632 522
Unadjusted period prevalence (%) 0.22 0.22 0.23
Median age at first event (years) 48.24 46.83 49.95

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1012
Matched controls
10119
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G56.8
ICD-10 Finland
Other mononeuropathies of upper limb
2003.9
323.0
449
*
G56.9
ICD-10 Finland
Mononeuropathy of upper limb, unspecified
2003.9
323.0
449
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
45.5
251.0
310
97
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
369.7
211.1
206
7
ACC51
NOMESCO Finland
Release of median nerve
396.8
138.3
136
*
3548X
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Other mononeuritis of upper limb
+∞
126.8
119
*
G56.2
ICD-10 Finland
Lesion of ulnar nerve
93.4
92.0
101
12
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
82.2
74.4
83
11
G54.0
ICD-10 Finland
Brachial plexus disorders
42.5
69.2
86
22
N03AX16
ATC
pregabalin; oral
3.5
57.2
328
1209
N03AX12
ATC
gabapentin; oral
4.1
51.5
232
691
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.1
45.8
317
1306
N02AX02
ATC
tramadol; systemic, rectal
2.6
45.3
501
2754
ACC53
NOMESCO Finland
Release of ulnar nerve
434.9
42.5
42
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
39.7
532
3165
XA402
NOMESCO Finland
ENMG
15.3
39.5
66
46
M79.6
ICD-10 Finland
Pain in limb
2.5
38.1
411
2166
M25.5
ICD-10 Finland
Pain in joint
2.6
35.1
340
1672
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.8
34.1
159
475
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.7
30.7
92
175
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.1
30.1
187
691
M01AH05
ATC
etoricoxib; oral
2.2
30.1
644
4516
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
4.2
28.6
114
294
N06AX21
ATC
duloxetine; oral
3.3
27.1
146
486
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
25.6
137
453
M54.5
ICD-10 Finland
Low back pain
2.2
25.3
349
1976
N02BE01
ATC
paracetamol; systemic, rectal
2.4
24.8
866
7181
M03BX02
ATC
tizanidine; oral
2.0
24.1
654
4827
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.3
23.1
89
222
G56.4
ICD-10 Finland
Causalgia
+∞
23.0
22
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
23.0
397
2446
M01AB05
ATC
diclofenac; systemic, rectal
2.0
22.6
690
5258
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
4.7
22.5
78
175
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
22.3
369
2227
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.5
22.0
107
327
X58
ICD-10 Finland
Exposure to other specified factors
2.6
20.5
171
744
L08
ICPC
Shoulder symptom/complaint
2.3
19.9
204
989
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
19.9
228
1165
5851
FHL
Rib resection due to local change or compression
+∞
19.9
19
*
M02AA07
ATC
piroxicam; topical
1.9
19.6
370
2324
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.2
19.5
109
368
M54.4
ICD-10 Finland
Lumbago with sciatica
2.5
19.3
172
775
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
3.5
19.0
91
275
G56.3
ICD-10 Finland
Lesion of radial nerve
56.1
19.0
22
*
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
101.9
18.6
20
*
ZXA05
NOMESCO Finland
Left side
2.1
18.3
253
1400
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
18.1
266
1508
M01AE02
ATC
naproxen; oral, rectal
1.8
18.0
571
4240
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
7.7
17.8
41
55
M01AX17
ATC
nimesulide; oral
2.1
17.8
241
1321
R20.2
ICD-10 Finland
Paraesthesia of skin
3.3
17.5
93
304
M77.1
ICD-10 Finland
Lateral epicondylitis
3.0
17.2
102
360
R03AC02
ATC
salbutamol; inhalant
1.8
16.7
519
3786
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
16.7
16
*
ZXA00
NOMESCO Finland
Right side
2.0
16.6
265
1544
G58.8
ICD-10 Finland
Other specified mononeuropathies
91.6
16.6
18
*
N06AA09
ATC
amitriptyline; systemic
2.8
16.5
114
442
G57.6
ICD-10 Finland
Lesion of plantar nerve
12.4
16.4
29
24
R51.80
ICD-10 Finland
Headache
2.3
16.4
163
772
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.6
16.2
74
215
G44.2
ICD-10 Finland
Tension-type headache
2.4
16.1
148
675
A02BC02
ATC
pantoprazole; systemic
1.7
15.7
626
4889
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
15.6
369
2453
M01AH01
ATC
celecoxib; oral (coxibs)
2.1
15.3
186
964
S18
ICPC
Laceration/cut
1.8
15.2
391
2665
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.8
15.2
101
385
Z50.1
ICD-10 Finland
Other physical therapy
3.5
14.8
70
210
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
14.8
478
3483
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
14.5
255
1531
J01DB01
ATC
cefalexin; oral
1.8
14.4
802
6838
M48.0
ICD-10 Finland
Spinal stenosis
2.6
14.2
111
462
M89.0
ICD-10 Finland
Algoneurodystrophy
14.7
14.1
23
16
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
5.7
14.0
40
73
M01AC06
ATC
meloxicam; systemic, rectal
1.7
13.9
344
2303
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
5.6
13.9
40
74
3530A
ICD-9 Finland
Nerve root and plexus disorders, Brachial plexus lesions
+∞
13.6
13
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
13.6
170
892
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.6
13.5
47
107
G54.9
ICD-10 Finland
Nerve root and plexus disorder, unspecified
34.5
13.5
17
5
J01DA01
ATC
[U] cefalexin; systemic
1.7
13.5
599
4721
L03
ICPC
Low back symptom/complaint
1.9
13.4
226
1329
ZXH06
SPAT
NA
5.4
13.3
39
74
M47.9
ICD-10 Finland
Spondylosis, unspecified
5.6
13.2
38
70
M54.2
ICD-10 Finland
Cervicalgia
3.0
13.2
77
270
H02AB06
ATC
prednisolone; systemic
1.7
13.2
437
3173
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
12.4
13.1
23
19
M54.1
ICD-10 Finland
Radiculopathy
4.0
13.1
52
135
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
13.1
79
282
J01AA02
ATC
doxycycline; systemic
1.7
12.7
756
6406
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
5.0
12.6
40
83
L12
ICPC
Hand/finger symptom/complaint
2.2
12.6
138
680
3549X
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Mononeuritis of upper limb, unspecified
+∞
12.5
12
*
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
24.6
12.5
17
7
SPAT1153
SPAT
Removal of sutures
1.7
12.5
289
1884
A02BC01
ATC
omeprazole; systemic
1.8
12.3
260
1647
R52.9
ICD-10 Finland
Pain, unspecified
2.7
12.2
84
328
AA1AD
NOMESCO Finland
CT of head and brain
1.9
12.1
209
1236
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.4
12.1
43
101
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
7.4
12.0
28
39
L01
ICPC
Neck symptom/complaint
2.2
12.0
136
681
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
11.8
85
339
R52.2
ICD-10 Finland
Other chronic pain
4.3
11.8
43
103
N03AE01
ATC
clonazepam; systemic
3.0
11.7
68
238
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
11.7
209
1250
J01FF01
ATC
clindamycin; systemic
1.7
11.7
265
1709
M01AH02
ATC
rofecoxib; oral
2.2
11.7
130
647
G56.1
ICD-10 Finland
Other lesions of median nerve
65.7
11.6
13
*
A02BC03
ATC
lansoprazole; oral
1.7
11.6
277
1815
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
11.6
264
1706
R42
ICD-10 Finland
Dizziness and giddiness
1.9
11.6
193
1126
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
5.1
11.5
35
70
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
5.1
11.3
35
71
M50.3
ICD-10 Finland
Other cervical disc degeneration
5.2
11.3
34
67
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
11.3
673
5597
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
11.3
109
507
M54.3
ICD-10 Finland
Sciatica
3.0
11.2
65
228
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.9
11.0
44
116
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
11.0
503
3908
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.2
10.9
111
528
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
3.0
10.9
63
220
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
5.0
10.9
34
70
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.6
10.9
82
336
C07AB07
ATC
bisoprolol; oral
1.6
10.7
400
2945
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
10.7
395
2901
M79.1
ICD-10 Finland
Myalgia
2.1
10.7
121
607
N03AF02
ATC
oxcarbazepine; oral
4.3
10.6
38
90
M03BC51
ATC
orphenadrine, combinations; systemic
1.7
10.5
277
1857
3542A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Lesion of ulnar nerve
+∞
10.4
10
*
N06AB04
ATC
citalopram; systemic
1.8
10.4
214
1335
M01AE01
ATC
ibuprofen; systemic, rectal
1.9
10.4
892
8089
L16
ICPC
Ankle symptom/complaint
2.4
10.3
87
377
J01CA04
ATC
amoxicillin; systemic
1.6
10.3
774
6732
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
10.2
198
1211
SPAT1301
SPAT
No procedures
1.7
10.2
275
1854
A02BC05
ATC
esomeprazole; systemic
1.6
10.1
375
2746
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
10.1
242
1580
G50.1
ICD-10 Finland
Atypical facial pain
11.4
10.1
18
16
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
11.4
10.1
18
16
R06.0
ICD-10 Finland
Dyspnoea
1.8
10.0
212
1330
M77.0
ICD-10 Finland
Medial epicondylitis
4.8
10.0
32
68
WX110
NOMESCO Finland
Local anesthesy
1.5
10.0
643
5357
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
5.1
9.9
30
60
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
9.9
118
605
L11
ICPC
Wrist symptom/complaint
2.6
9.8
72
292
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
9.6
91
421
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.4
9.5
44
132
K02.1
ICD-10 Finland
Caries of dentine
1.5
9.4
533
4284
M01AB55
ATC
diclofenac, combinations; oral
2.6
9.4
67
267
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.8
9.4
170
1013
ACC52
NOMESCO Finland
Release of radial nerve
+∞
9.4
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
9.4
373
2770
M79.7
ICD-10 Finland
Fibromyalgia
3.8
9.3
38
103
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
9.2
86
394
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
9.1
173
1048
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.6
9.1
246
1654
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
11.6
9.1
16
14
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.4
9.0
74
318
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
5.1
9.0
27
54
N06AX11
ATC
mirtazapine; oral
1.6
9.0
286
2006
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
4.7
9.0
29
63
G51.0
ICD-10 Finland
Bell palsy
24.2
8.9
12
5
NCL99
NOMESCO Finland
Other operation on muscle or tendon of elbow or forearm
12.7
8.9
15
12
N05AH04
ATC
quetiapine; oral
1.8
8.8
157
930
WX204
NOMESCO Finland
Axillary plexus blockaced
3.7
8.8
37
103
M65.3
ICD-10 Finland
Trigger finger
3.2
8.8
44
141
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
8.7
174
1069
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
50.4
8.7
10
*
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
50.4
8.7
10
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
8.6
135
768
N01
ICPC
Headache
2.1
8.6
94
465
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
4.3
8.5
30
71
N06AA10
ATC
nortriptyline; systemic
4.3
8.5
30
71
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
8.5
141
815
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
6.5
8.5
21
33
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.2
8.5
43
139
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
8.5
59
234
NBG10
NOMESCO Finland
Acromioplastia
4.0
8.4
32
82
R53
ICD-10 Finland
Malaise and fatigue
1.7
8.4
174
1082
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
8.3
163
996
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
8.3
238
1619
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
5.3
8.3
24
46
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
8.3
407
3141
R01AD09
ATC
mometasone; nasal
1.5
8.3
416
3226
T92.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of upper limb
9.5
8.3
16
17
M47.82
ICD-10 Finland
Other spondylosis, cervical region
3.3
8.3
40
125
WZA90
NOMESCO Finland
Other doctors statement
1.7
8.2
204
1339
S06.0
ICD-10 Finland
Concussion
2.1
8.2
95
482
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.2
8.1
81
383
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
8.1
348
2605
2401
FHL
Nerve exploration (includes biopsy and removal of local change)
33.6
8.1
10
*
7233A
ICD-9 Finland
Other disorders of cervical region, Cervicobrachial syndrome (diffuse)
33.6
8.1
10
*
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
11.8
8.1
14
12
L30.3
ICD-10 Finland
Infective dermatitis
3.3
8.1
39
122
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
8.1
266
1872
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
8.1
534
4380
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
8.0
599
5027
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.6
8.0
58
232
R03DC03
ATC
montelukast; oral
1.8
8.0
144
856
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.8
8.0
137
801
J01FA06
ATC
roxithromycin; oral
1.5
8.0
360
2723
SPAT1263
SPAT
Sampling
1.5
8.0
367
2790
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
8.0
148
888
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
7.9
72
325
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
5.0
7.9
24
49
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
5.0
7.9
24
49
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
7.8
383
2943
7261X
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]
8.5
7.8
16
19
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
7.7
95
493
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
7.7
111
614
J01MA02
ATC
ciprofloxacin; systemic
1.5
7.6
337
2534
EBA00
NOMESCO Finland
Extraction of tooth
1.5
7.6
290
2109
T92.4
ICD-10 Finland
Sequelae of injury of nerve of upper limb
18.5
7.6
11
6
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.8
7.6
30
80
G58.9
ICD-10 Finland
Mononeuropathy, unspecified
25.2
7.6
10
*
H02AB04
ATC
methylprednisolone; systemic
1.8
7.6
133
783
M01AC01
ATC
piroxicam; systemic, rectal
1.9
7.6
119
675
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.6
465
3739
E0000UV
ATC
NA
1.5
7.5
349
2647
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
7.5
83
411
SGA01
NOMESCO Finland
Tooth opening as first aid
1.7
7.4
147
902
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.2
7.4
74
352
J46
ICD-10 Finland
Status asthmaticus
4.1
7.4
27
67
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
3.8
7.4
29
77
M70.6
ICD-10 Finland
Trochanteric bursitis
1.9
7.4
101
546
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
7.4
354
2702
H53.1
ICD-10 Finland
Subjective visual disturbances
2.4
7.4
63
277
UJF32
NOMESCO Finland
Coloscopy
1.6
7.4
221
1516
M01AX05
ATC
glucosamine; oral
1.7
7.3
157
985
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
7.3
255
1815
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
7.3
468
3785
N03AX09
ATC
lamotrigine; oral
2.6
7.3
50
196
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
7.2
177
1154
L92
ICPC
Shoulder syndrome
4.0
7.2
27
69
J01FA10
ATC
azithromycin; systemic
1.4
7.2
539
4485
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.5
7.2
54
224
TAB00
NOMESCO Finland
Lumbar puncture
2.6
7.2
48
187
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.1
7.2
75
365
R03BA05
ATC
fluticasone; inhalant
1.7
7.2
157
990
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.0
7.2
38
128
TAD02
NOMESCO Finland
Sympathetic block of ganglion stellatum
30.2
7.2
9
*
A02BA02
ATC
ranitidine; systemic
1.7
7.1
169
1091
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
7.1
105
585
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
7.1
243
1722
WZC00
SPAT
NA
2.8
7.1
43
158
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
7.1
217
1496
C07AA05
ATC
propranolol; systemic
1.6
7.1
174
1132
SPAT1310
SPAT
Counselling related to known health issue
1.5
7.0
269
1953
A46
ICD-10 Finland
Erysipelas
1.8
7.0
111
633
M03BX01
ATC
baclofen; systemic
4.5
7.0
23
52
M13.9
ICD-10 Finland
Arthritis, unspecified
2.2
6.9
68
320
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
6.9
68
320
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
3.1
6.9
36
120
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
6.9
88
466
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.5
6.9
54
227
A01
ICPC
Pain general/multiple sites
2.2
6.9
66
310
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.5
6.9
51
209
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
6.9
115
667
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
2.5
6.8
51
210
WX200
NOMESCO Finland
Interscalenous plexus blockade
4.0
6.8
25
63
WX290
NOMESCO Finland
Other blockade of nerve
1.4
6.8
399
3158
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.5
6.7
29
84
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
6.7
86
452
WW200
SPAT
NA
1.9
6.7
105
595
R06AE07
ATC
cetirizine; oral
1.4
6.7
392
3102
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
3.0
6.6
36
124
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.0
6.6
81
420
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.6
6.6
159
1030
J01FA09
ATC
clarithromycin; systemic
1.5
6.5
281
2089
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.0
6.5
34
114
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.5
503
4178
G47.3
ICD-10 Finland
Sleep apnoea
1.6
6.5
184
1244
N03AF01
ATC
carbamazepine; oral, rectal
2.5
6.5
46
186
G57.9
ICD-10 Finland
Mononeuropathy of lower limb, unspecified
70.3
6.4
7
*
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
2.6
6.4
45
179
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.4
334
2580
M22.4
ICD-10 Finland
Chondromalacia patellae
2.9
6.4
37
132
Z71.8
ICD-10 Finland
Other specified counselling
1.5
6.4
212
1488
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
6.4
160
1048
S22.3
ICD-10 Finland
Fracture of rib
2.3
6.4
59
270
M24.2
ICD-10 Finland
Disorder of ligament
4.6
6.3
20
44
L86
ICPC
Back syndrome with radiating pain
2.4
6.3
48
202
2404
FHL
Nerve dissection (obturator 9364, Morton 9273, nerve tympanicus 4162)
+∞
6.3
6
*
35708
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Alterius nervi
+∞
6.3
6
*
R60.0
ICD-10 Finland
Localized oedema
1.9
6.2
86
466
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.6
6.2
191
1314
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.7
6.2
38
142
N02AA05
ATC
oxycodone; systemic
1.8
6.1
109
645
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
6.1
175
1183
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
4.3
6.1
21
50
M76.0
ICD-10 Finland
Gluteal tendinitis
4.1
6.1
22
55
S14.3
ICD-10 Finland
Injury of brachial plexus
12.6
6.1
10
8
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
12.6
6.1
10
8
R07.3
ICD-10 Finland
Other chest pain
1.9
6.1
83
448
SPAT1240
SPAT
Therapeutic discussion
1.8
6.0
94
532
G50.0
ICD-10 Finland
Trigeminal neuralgia
10.1
6.0
11
11
M75.8
ICD-10 Finland
Other shoulder lesions
2.9
6.0
33
115

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
420
2545
2.02
27.14
2.4
2.1
u/l
232.1
256.5
0.17
404
2399
(3013707) Erythrocyte sedimentation rate by Westergren method
862
6749
2.10
25.93
4.8
3.8
mm/h
11.2
11.4
0.10
816
6233
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
427
2819
1.82
19.85
2.8
2.5
u/l
55.0
56.9
0.50
403
2594
(3019150) Specific gravity of Urine by Refractometry
303
1847
1.87
17.91
4.9
3.6
kg/l
1.0
1.0
0.69
44
245
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
855
7101
1.79
16.26
4.4
3.9
pmol/l
14.8
14.7
0.83
799
6492
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
612
4685
1.65
15.39
6.1
6.4
umol/l
10.7
11.6
0.90
579
4452
(3024561) Albumin [Mass/volume] in Serum or Plasma
506
3718
1.64
14.77
5.0
5.0
g/l
36.0
35.9
0.11
474
3480
(3013826) Glucose [Moles/volume] in Serum or Plasma
661
5217
1.63
14.24
5.2
4.7
mmol/l
6.8
6.6
0.85
628
4876
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
558
4238
1.61
13.99
7.1
6.9
mmol/l
1.2
1.2
0.38
484
3567
(3031040) Bacteria [#/volume] in Urine by Automated count
718
5798
1.63
13.97
5.1
4.0
e6/l
37.7
2130.1
1.56
11
89
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
428
3049
1.64
13.91
3.4
3.3
u/l
38.4
32.7
0.38
410
2899
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
252
1555
1.79
13.89
1.4
1.2
iu/ml
16.2
33.7
3.98
75
489
(3019198) Lymphocytes [#/volume] in Blood
604
4686
1.61
13.79
5.9
5.8
e9/l
2.2
1.9
0.60
552
4150
(3001604) Monocytes [#/volume] in Blood
588
4543
1.60
13.58
5.9
5.8
e9/l
0.6
0.6
0.30
522
3946
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
836
7077
1.66
12.87
8.2
7.4
u/l
75.8
77.9
0.85
802
6659
(3006315) Basophils [#/volume] in Blood
585
4561
1.57
12.66
5.9
5.8
e9/l
0.0
0.0
0.49
525
3960
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
307
2062
1.67
12.29
1.8
1.7
mg/l
1.5
1.1
0.44
230
1538
(3013115) Eosinophils [#/volume] in Blood
599
4718
1.56
12.24
6.1
6.1
e9/l
0.2
0.2
1.27
547
4161
(3019550) Sodium [Moles/volume] in Serum or Plasma
1063
9704
2.21
12.22
18.9
14.3
mmol/l
139.5
139.7
2.36
1045
9449
(3023103) Potassium [Moles/volume] in Serum or Plasma
1065
9737
2.22
12.07
18.8
14.4
mmol/l
4.0
4.0
1.06
1043
9469
(3037467) Urinalysis macro (dipstick) panel - Urine
745
6176
1.58
12.06
4.6
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
204
1233
1.80
11.90
2.1
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
657
5304
1.55
11.87
9.5
9.3
e9/l
4.2
4.1
0.41
610
4642
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
233
1470
1.73
11.71
1.4
1.2
u/ml
5.5
13.0
1.56
80
583
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
965
8561
1.78
11.68
5.2
4.5
mu/l
1.8
2.0
1.15
908
7893
(4034850)
72
295
2.54
11.68
8.2
8.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
446
3312
1.56
11.67
4.1
3.2
ng/l
66.3
54.4
0.12
285
2166
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1036
9402
2.00
11.57
18.0
12.6
mg/l
21.4
23.5
1.26
853
7295
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
505
3861
1.55
11.57
6.5
6.1
mmol/l
1.2
1.2
0.37
467
3500
(3032080) INR in Blood by Coagulation assay
458
3443
1.55
11.23
7.1
8.4
inr
1.1
1.2
2.36
130
1045
(3007853) Bacteria identified in Skin by Aerobe culture
168
980
1.84
10.97
1.7
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
537
4194
1.52
10.96
4.2
3.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
560
4417
1.52
10.89
4.2
3.3
estimate
0.0
0.0
0.00
82
823
(3037522) Nuclear Ab [Titer] in Serum
197
1208
1.76
10.88
1.5
1.3
titre
475.7
533.0
0.21
37
253
(4027681)
24
52
4.69
10.50
1.3
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
452
3430
1.52
10.40
4.4
3.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
559
4447
1.50
10.19
5.4
4.6
estimate
0.0
0.0
0.50
88
839
(3009261) Glucose [Presence] in Urine by Test strip
562
4485
1.49
10.03
4.3
3.3
estimate
0.0
0.0
0.80
86
800
(3018418) pH of Serum or Plasma
349
2522
1.55
9.97
4.1
4.0
ph
7.4
7.4
0.09
58
505
(3014576) Chloride [Moles/volume] in Serum or Plasma
171
1040
1.76
9.66
6.6
7.1
mmol/l
104.0
104.3
0.26
159
1016
(3008152) Bicarbonate [Moles/volume] in Arterial blood
97
492
2.06
9.54
7.6
9.3
mmol/l
24.5
24.5
0.01
91
463
(3018677) aPTT in Platelet poor plasma by Coagulation assay
207
1334
1.67
9.46
1.9
2.1
s
30.0
29.9
0.05
202
1287
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
450
3464
1.49
9.42
2.0
1.9
pmol/l
91.7
95.3
0.93
223
1820
(3003396) Base excess in Arterial blood by calculation
152
900
1.79
9.40
6.5
9.5
mmol/l
1.8
1.1
1.81
120
715
(3026008) Bacteria identified in Urine by Culture
331
2393
1.54
9.34
3.3
2.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
323
2328
1.54
9.22
4.7
3.7
estimate
0.0
0.0
0.69
89
809
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
242
1633
1.61
9.20
4.1
3.6
ng/l
296.4
474.0
0.49
189
1225
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
60
4.06
8.81
1.0
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
138
810
1.80
8.78
6.8
10.0
%
95.8
95.6
0.12
133
783
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
74
3.71
8.75
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
123
702
1.84
8.57
3.9
3.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
319
2326
1.51
8.53
6.2
6.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
395
3012
1.47
8.46
6.1
5.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
539
4371
1.44
8.28
6.1
5.7
%
56.0
57.2
1.50
519
4099
(3019069) Monocytes/100 leukocytes in Blood
531
4301
1.43
8.18
6.5
6.2
%
8.5
8.6
0.60
508
4038
(4010399)
110
618
1.86
8.05
1.5
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
543
4425
1.43
8.04
6.4
6.0
%
28.7
28.0
0.75
519
4138
(3007930) Methemoglobin/Hemoglobin.total in Blood
67
315
2.20
8.03
3.7
8.9
%
0.8
0.9
1.06
62
297
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
289
2096
1.51
7.83
2.3
2.0
mg/l
2.9
2.9
0.24
247
1798
(3022096) Basophils/100 leukocytes in Blood
513
4152
1.42
7.82
6.3
5.9
%
0.7
0.7
0.75
488
3880
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
106
598
1.85
7.66
1.7
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
280
2031
1.50
7.55
4.5
3.3
—
—
—
0
0
(3019977) pH of Arterial blood
19
45
4.28
7.49
2.4
4.2
ph
7.4
7.4
—
6
15
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
144
899
1.69
7.35
6.7
9.4
kpa
5.1
5.1
0.21
136
863
(3027801) Oxygen [Partial pressure] in Arterial blood
144
899
1.69
7.35
6.7
9.4
kpa
12.7
12.2
0.41
136
865
(3006504) Eosinophils/100 leukocytes in Blood
523
4280
1.41
7.34
6.3
5.9
%
3.1
2.8
2.89
500
3997
(3002173) Hemoglobin [Mass/volume] in Arterial blood
125
758
1.73
7.10
7.3
10.2
g/l
121.5
121.9
0.06
118
736
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
251
1806
1.50
6.98
1.8
1.6
pmol/l
413.7
26368253.9
1.46
216
1517
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
65
320
2.09
6.96
3.7
8.8
%
1.7
1.6
0.42
60
302
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
49
216
2.32
6.87
1.7
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
37
143
2.64
6.84
2.8
2.4
—
—
—
0
0
(3012544) pH of Venous blood
128
791
1.70
6.79
3.8
3.7
—
7.4
—
0
6
(3000475) Leukocytes [#/volume] in Synovial fluid
45
192
2.40
6.78
1.8
1.6
e6/l
6690.4
18786.0
2.06
38
141
(40761511) CBC panel - Blood by Automated count
1059
9964
1.76
6.59
16.9
12.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
25
80
3.17
6.46
1.6
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
299
2270
1.43
6.22
4.6
4.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
198
1387
1.52
6.22
4.0
3.6
mmol/l
0.8
0.8
0.43
187
1315
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
19
52
3.70
6.21
1.2
1.1
u/l
1.1
1.2
0.54
12
30
(3044941) Cell count panel - Synovial fluid
32
121
2.69
6.19
1.2
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
107
646
1.72
6.18
3.4
2.7
g/l
67.1
67.0
0.05
100
600
(3017446) Testosterone [Moles/volume] in Serum or Plasma
121
757
1.67
6.13
2.5
2.2
nmol/l
14.2
13.3
0.56
108
687
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
27
94
2.92
6.07
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
48
222
2.21
6.04
1.3
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
243
1790
1.45
5.92
3.0
2.5
e6/l
6.2
5.8
0.16
219
1592
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
190
1336
1.51
5.84
1.8
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
180
1254
1.52
5.78
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
990
9223
1.52
5.70
4.7
4.2
mmol/l
6.0
5.9
1.38
934
8468
(3044640) Blood type and Crossmatch panel - Blood
356
2824
1.38
5.65
2.5
2.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
303
2340
1.40
5.65
2.6
2.6
umol/l
5218.1
5691.6
0.07
274
2068
(3014111) Lactate [Moles/volume] in Serum or Plasma
116
734
1.65
5.63
5.9
7.6
mmol/l
1.4
1.3
0.13
111
705
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
942
8698
1.45
5.59
6.2
5.2
mmol/mol
40.0
39.3
1.49
891
8124
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
113
713
1.65
5.55
3.5
2.6
ml/min/173m2
73.1
67.2
0.66
51
285
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
450
3714
1.35
5.51
2.6
2.2
nmol/l
76.9
76.1
0.21
412
3364
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
25
4.84
5.50
2.8
3.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
25
4.84
5.50
2.8
3.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
119
763
1.62
5.48
3.8
3.7
mmol/l
2.2
2.0
0.28
104
618
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
139
926
1.57
5.46
1.7
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
35
148
2.41
5.43
1.1
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
373
3001
1.36
5.37
3.1
3.5
mmol/l
2.3
2.4
1.31
331
2644
(3019060) Gas panel - Arterial blood
86
512
1.73
5.24
5.1
7.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
332
2631
1.37
5.24
3.8
3.1
e6/l
29.9
86.5
1.40
263
2012
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1071
10195
1.70
5.22
12.1
9.8
u/l
27.0
27.2
0.07
1046
9865
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
45
218
2.11
5.09
1.8
1.2
mg/l
547.6
494.4
0.28
45
203
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
70
396
1.82
5.08
2.3
2.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
24
87
2.80
5.06
1.3
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
50
253
2.02
5.05
1.5
1.5
ug/g
258.2
283.0
0.41
24
140
(3018095) Leukocytes [#/volume] in Urine
382
3109
1.34
5.04
4.3
3.6
e6/l
54.7
84.7
0.81
284
2183
(3004789) Transferrin [Mass/volume] in Serum or Plasma
171
1213
1.48
5.02
2.8
2.5
g/l
2.3
2.3
0.29
161
1132
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
35
154
2.31
5.00
1.7
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
470
3947
1.32
4.97
3.0
2.7
ug/l
137.0
131.6
0.09
442
3661
(3022948) Iron [Moles/volume] in Serum or Plasma
182
1310
1.46
4.96
2.8
2.5
umol/l
12.7
13.8
1.07
168
1212
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
89
544
1.69
4.95
1.4
1.3
—
35.1
—
0
28
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
175
1252
1.47
4.92
2.2
1.8
%
1.6
1.5
0.90
165
1110
(3008898) HLA-B27 [Presence]
60
328
1.87
4.86
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
135
918
1.53
4.85
1.6
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
159
1124
1.48
4.74
2.8
2.6
%
20.8
24.0
2.39
137
974
(3022621) pH of Urine by Test strip
88
543
1.67
4.73
3.0
2.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
728
6523
1.31
4.69
3.6
3.1
u/l
52.5
48.5
0.49
699
6108
(3015171) Extractable nuclear Ab [Units/volume] in Serum
63
355
1.82
4.65
1.4
1.2
u/ml
0.2
1.4
—
10
23
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
219
1650
1.40
4.64
1.6
1.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
21
4.79
4.53
1.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
731
6569
1.31
4.53
4.0
3.5
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
37
175
2.15
4.48
4.6
13.5
mmol/l
103.7
105.6
0.83
32
159
(3039000) Anion gap in Blood
37
175
2.15
4.48
4.6
13.5
mmol/l
12.4
11.4
0.51
32
159
(3000330) Specific gravity of Urine by Test strip
68
397
1.76
4.47
3.4
3.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
47
244
1.97
4.45
5.6
3.9
mmol/l
3.9
3.9
0.05
39
224
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
39
189
2.10
4.44
1.7
1.2
e6/l
25.5
8.7
0.45
31
135
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
39
189
2.10
4.44
1.7
1.3
e6/l
61.6
1124.4
0.87
34
145
(3009508) Creatinine [Moles/volume] in Urine
336
2726
1.33
4.43
3.5
3.1
mmol/l
7.4
7.9
0.99
293
2308
(3025941) Bacteria identified in Stool by Culture
81
498
1.67
4.43
1.4
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
47
245
1.96
4.40
2.2
2.3
g/l
0.5
1.0
0.56
41
219
(3022217) INR in Platelet poor plasma by Coagulation assay
147
1039
1.48
4.39
19.2
22.4
inr
1.3
1.3
0.06
13
149
(3004588) Protein electrophoresis panel - Serum or Plasma
86
539
1.64
4.37
3.1
2.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
21
77
2.76
4.36
1.2
1.2
e6/l
38412.5
128985.6
0.52
16
55
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
133
923
1.50
4.35
2.9
4.4
u/l
240.6
242.2
0.04
128
873
(3019309) Folate [Moles/volume] in Red Blood Cells
197
1474
1.41
4.33
1.9
1.7
nmol/l
1123.4
1236.2
1.08
155
1114
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
257
2010
1.36
4.32
1.4
1.2
u/ml
1.9
1.6
0.08
82
550
(3035637) Corticotropin [Mass/volume] in Plasma
26
108
2.44
4.24
1.1
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
294
2354
1.33
4.22
3.5
2.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
31
140
2.25
4.21
1.9
1.3
mmol/l
80.2
63.5
0.82
26
116
(3000494) Fungus identified in Specimen by Culture
152
1095
1.45
4.12
1.4
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
36
175
2.09
4.09
1.4
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
142
1015
1.46
4.01
2.5
2.8
umol/l
6.4
9.0
1.33
118
896
(3000764) Benzodiazepines [Presence] in Urine
59
342
1.76
4.00
2.7
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
55
313
1.80
3.97
2.8
1.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
100
666
1.55
3.97
3.6
2.8
ng/l
162.9
196.4
0.38
94
607
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
192
1452
1.39
3.96
3.3
2.6
e6/l
1.4
1.1
0.27
124
796
(3028300) Cannabinoids [Presence] in Urine
59
345
1.75
3.89
2.7
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
119
828
1.49
3.85
1.9
2.1
nmol/l
375.4
368.8
0.16
111
769
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
287
2322
1.31
3.78
2.7
3.0
ng/l
1091.3
1171.7
0.16
249
1971
(3000991) Gas panel - Venous blood
103
699
1.52
3.76
7.1
9.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
42
224
1.91
3.72
1.4
2.0
g/l
39.6
38.2
0.69
36
197
(3020682) Albumin/Creatinine [Ratio] in Urine
324
2670
1.30
3.72
4.3
3.9
mg/mmol
8.8
8.1
0.10
220
1695
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
86
562
1.57
3.72
2.6
3.7
pmol/l
4.4
4.6
0.52
79
504
(3030467) Casts [#/volume] in Urine by Automated count
295
2401
1.31
3.72
3.9
3.0
e6/l
0.2
0.5
2.27
238
1791
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
101
686
1.52
3.68
2.7
2.4
ug/l
12.8
7.5
0.47
90
613
(3027008) Opiates [Presence] in Urine
58
344
1.72
3.66
2.7
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
57
337
1.73
3.64
2.8
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
285
1.79
3.61
1.4
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
285
1.79
3.61
1.4
2.1
g/l
3.8
3.8
0.06
37
209
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
285
1.79
3.61
1.4
2.1
g/l
7.0
7.3
0.50
39
218
(3047181) Lactate [Moles/volume] in Blood
44
241
1.86
3.61
4.7
11.1
mmol/l
1.7
1.3
0.48
36
211
(3020891) Body temperature
55
323
1.74
3.59
6.7
4.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
241
1916
1.33
3.58
1.6
1.5
nmol/l
20.4
20.9
0.22
215
1640
(3007164) IgA [Mass/volume] in Serum or Plasma
226
1785
1.33
3.51
1.8
1.4
g/l
2.3
2.4
0.45
146
1125
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
91
611
1.53
3.50
3.7
4.2
ng/l
81.6
86.9
0.26
83
540
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1016
9690
1.41
3.48
5.2
4.6
mmol/l
2.8
2.8
1.45
962
9001
(3024731) MCV [Entitic volume]
1103
10698
1.70
3.47
25.2
18.6
fl
91.0
90.9
0.17
1092
10548
(3014051) Protein [Presence] in Urine by Test strip
35
180
1.97
3.46
2.6
2.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
1103
10699
1.70
3.45
25.2
18.6
pg
30.4
30.3
0.28
1092
10547
(3021788) Differential panel - Synovial fluid
29
139
2.11
3.45
1.4
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
267
1.79
3.45
1.3
2.2
g/l
3.0
3.1
0.07
37
214
(3033658) Prothrombin time (PT) actual/Normal
283
2312
1.30
3.44
4.2
3.7
%
91.7
92.1
0.10
276
2254
(3026361) Erythrocytes [#/volume] in Blood
1103
10700
1.70
3.44
25.3
18.6
e12/l
4.5
4.5
1.96
1085
10407
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
48
275
1.78
3.42
1.8
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
306
2528
1.29
3.41
3.3
3.2
mg/l
259.3
385.2
0.24
208
1615
(3041096) Erythrocytes [Presence] in Urine by Automated
299
2463
1.29
3.41
3.4
3.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1103
10702
1.69
3.41
25.4
18.7
e9/l
6.9
6.6
1.08
1085
10402
(3000963) Hemoglobin [Mass/volume] in Blood
1103
10702
1.69
3.41
25.4
18.8
g/l
136.0
136.8
0.94
1093
10545
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
57
344
1.69
3.40
2.4
2.1
ug/l
6.2
2.2
0.75
50
315
(3011288) Drugs identified in Urine by Screen method
40
217
1.87
3.39
2.8
2.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1102
10693
1.68
3.36
25.4
18.7
e9/l
252.0
251.7
0.05
1087
10419
(3052851) Hemolysis interference index of Serum or Plasma
44
247
1.81
3.36
2.5
3.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
91
618
1.51
3.34
2.6
3.0
e9/l
4.0
4.2
0.36
76
489
(3026782) Osmolality of Urine
214
1693
1.32
3.28
3.0
2.7
mosm/kgh2o
583.3
550.3
0.83
190
1455
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
266
1.76
3.20
1.4
2.1
g/l
9.9
10.6
0.80
40
229
(3005719) IgG [Mass/volume] in Serum or Plasma
101
710
1.46
3.14
3.6
2.8
g/l
10.5
10.5
0.01
93
657
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
44
2.98
3.14
2.7
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
856
8004
1.27
3.12
20.1
15.6
%
13.7
13.6
0.38
845
7839
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1000
9546
1.36
3.10
4.8
4.2
mmol/l
4.7
4.7
1.01
953
8917
(3045414) Leukocytes [Presence] in Urine
60
377
1.62
3.09
2.1
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
30
153
1.99
3.06
1.3
1.3
—
—
—
0
0
(4198724)
11
34
3.26
3.06
1.8
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
122
895
1.41
3.02
2.5
2.8
%
1.8
1.8
0.16
114
814
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
263
2167
1.28
2.96
2.5
2.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
9
6.69
2.87
1.2
1.4
ng/l
75.1
116.7
—
6
9
(3004716) Salmonella sp identified in Stool by Organism specific culture
73
490
1.52
2.86
1.6
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
137
1035
1.37
2.85
10.1
6.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
18
77
2.36
2.82
1.8
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
47
2.79
2.82
1.8
3.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
53
2.66
2.80
1.6
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
145
1109
1.35
2.80
5.9
6.2
mmol/l
1.0
1.0
0.17
140
1030
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
64
420
1.55
2.78
6.5
14.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
143
1094
1.35
2.75
2.7
2.4
ug/g
125.7
129.2
0.05
121
858
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
40
234
1.73
2.71
1.6
1.8
pmol/l
231.3
208.9
0.47
40
221
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
19
4.23
2.68
1.6
3.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
43
259
1.69
2.64
2.5
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
93
2.17
2.62
1.6
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
34
192
1.79
2.60
1.4
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
38
2.91
2.58
1.3
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
38
2.91
2.58
1.3
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
103
756
1.40
2.57
7.7
8.3
mmol/l
9.4
9.1
0.17
97
720
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
44
2.75
2.55
1.3
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
44
2.75
2.55
1.2
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
60
397
1.54
2.53
2.3
2.1
u/l
41.6
39.6
0.36
55
355
(3049717) Cytology report of Urine Cyto stain
49
309
1.61
2.53
2.6
2.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
72
496
1.48
2.52
1.7
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
42
255
1.67
2.51
3.4
3.5
mg/l
33.9
73.9
0.89
33
197
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
42
255
1.67
2.51
3.4
3.5
mg/l
36.9
30.4
0.37
33
199
(3016018) Differential panel - Cerebral spinal fluid
20
95
2.12
2.49
1.3
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
69
2.34
2.49
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
989
9496
1.29
2.40
4.7
4.2
mmol/l
1.5
1.5
0.21
943
8828
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
962
9206
1.27
2.39
4.3
3.8
mmol/l
1.3
1.3
0.03
916
8519
(3002619) Bacteria identified in Specimen by Culture
7
17
4.14
2.36
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
18
84
2.16
2.35
2.7
3.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
255
2154
1.24
2.28
5.5
4.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
671
6213
1.19
2.25
3.1
3.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
130
1013
1.32
2.24
1.3
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
460
4124
1.19
2.22
10.4
9.0
e9/l
0.0
0.0
0.16
382
3391
(3014765) Yersinia sp identified in Stool by Organism specific culture
43
273
1.60
2.20
1.3
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
42
2.63
2.19
3.2
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
192
1580
1.26
2.17
2.4
3.1
mmol/l
2.4
2.4
1.51
165
1403
(3051387) C reactive protein [Mass/volume] in Capillary blood
34
204
1.69
2.16
5.4
3.4
mg/l
22.4
25.6
0.29
21
130
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
278
2387
1.22
2.12
4.2
3.8
%
22.6
21.3
0.50
108
1049
(40760888) Immunoglobulin light chains.free panel - Serum
32
190
1.70
2.11
3.8
4.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
43
276
1.58
2.11
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
43
276
1.58
2.11
1.3
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
39
245
1.61
2.09
1.4
1.4
u/l
8.4
9.7
0.22
32
207
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
41
261
1.59
2.09
3.4
2.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
20
3.51
2.05
1.3
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
36
223
1.63
2.04
1.4
1.7
—
—
—
0
0
(44790049)
21
111
1.91
2.01
1.1
1.7
—
—
—
0
0
(44790047)
21
111
1.91
2.01
1.1
1.7
—
—
—
0
0
(44806118)
21
111
1.91
2.01
1.1
1.7
—
—
—
0
0
(44790048)
21
111
1.91
2.01
1.1
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
87
650
1.37
2.00
2.3
2.8
e9/l
72.2
73.4
0.11
70
499
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
217
1.63
1.99
1.3
1.7
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
51
2.37
1.95
1.5
1.4
ug/l
4.6
6.0
0.65
12
41
(3003327) Ova and parasites identified in Stool by Light microscopy
42
274
1.55
1.94
1.6
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
27
157
1.74
1.94
1.4
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
72
2.10
1.86
1.2
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
338
3797
0.84
1.86
3.4
2.6
—
—
—
0
0
(4094501)
41
269
1.54
1.86
1.2
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
30
183
1.66
1.83
1.8
2.2
g/l
126.3
130.6
0.37
23
143
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
101
1.90
1.81
3.0
2.5
—
—
—
0
0
(3000492) Spirometry study
123
982
1.28
1.80
1.7
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
35
2.58
1.80
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
29
2.77
1.79
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
338
2999
1.18
1.78
4.6
4.4
ug/l
1.6
2.1
2.93
313
2731
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
35
225
1.57
1.75
1.3
1.2
u/ml
2.7
2.9
—
5
36
(3037756) Immunofixation for Serum or Plasma
27
163
1.67
1.72
2.2
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
165
1372
1.24
1.72
1.5
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
61
2.14
1.72
2.8
3.9
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
50
349
1.45
1.72
1.2
1.0
—
0.9
—
0
6
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
227
1.56
1.69
1.3
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
165
1377
1.23
1.67
3.6
2.8
e6/l
2.0
2.5
0.41
98
722
(46235355) HIV 1 and 2 tests - Meaningful Use set
194
1647
1.21
1.66
1.7
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
31
2.59
1.66
1.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
83
1.94
1.65
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
83
1.94
1.65
1.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
83
1.94
1.65
1.6
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
22
127
1.75
1.65
3.8
3.9
%
1.3
1.6
0.18
14
110
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
225
0.48
1.64
1.2
1.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
105
1.82
1.63
1.2
1.4
pmol/l
191.6
337.6
3.19
13
83
(3013139) Helicobacter pylori Ag [Presence] in Stool
77
585
1.34
1.63
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
80
1032
0.76
1.61
1.8
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
15
77
1.96
1.59
1.8
2.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
6
20
3.01
1.58
1.7
1.3
mg/l
0.2
269.7
—
6
13
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
26
2.70
1.58
1.3
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
26
2.70
1.58
1.3
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
50
2.21
1.57
1.4
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
145
1.67
1.55
1.0
1.5
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
13
64
2.04
1.54
1.2
1.1
—
62.2
—
0
5
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
13
64
2.04
1.54
1.2
1.1
—
74.4
—
0
5
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
71
1.98
1.54
2.0
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
939
9071
1.19
1.51
14.6
11.5
ml/min/173m2
84.6
83.2
1.37
797
7446
(4024509)
13
65
2.01
1.49
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
172
1.58
1.44
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
23
141
1.64
1.42
1.0
1.0
u/ml
1.8
2.0
—
6
68
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
157
1.61
1.41
1.5
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
52
698
0.73
1.40
1.5
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
96
1.78
1.39
1.3
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
129
1072
1.23
1.38
1.5
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
158
1.60
1.38
1.1
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
63
479
1.33
1.36
1.1
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
54
401
1.36
1.36
2.1
1.7
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
17
2.95
1.36
1.4
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
40
282
1.43
1.35
2.2
3.7
g/l
0.2
0.2
0.14
13
130
(3024471) HLA-A [Type]
0
39
0.00
1.34
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
42
2.15
1.34
6.1
3.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
61
1.98
1.33
1.7
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
108
885
1.24
1.32
3.4
4.5
ug/l
13.0
25.4
0.55
95
722
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
106
867
1.25
1.32
2.7
2.5
u/l
32.2
41.0
0.66
91
742
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
98
1.75
1.31
1.8
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
94
759
1.26
1.31
4.4
4.4
%
0.9
0.9
0.00
26
224
(3000034) Microalbumin [Mass/volume] in Urine
14
76
1.85
1.30
2.9
3.7
mg/l
60.4
17.9
—
9
56
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
91
1.77
1.29
1.8
1.5
%
49.0
59.8
0.38
11
67
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
35
2.29
1.27
1.9
3.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
27
179
1.52
1.24
2.4
4.0
u/ml
967.2
2056.3
0.32
27
168
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
9
45
2.01
1.23
1.8
1.7
u/field
3.6
5.7
—
9
36
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
196
1.49
1.22
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
280
2517
1.15
1.22
1.7
1.6
mmol/l
1.5
1.4
0.29
236
2128
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
132
1.60
1.21
1.2
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
47
349
1.36
1.21
1.9
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
249
1.42
1.16
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
44
326
1.36
1.15
1.9
1.6
mu/l
225.5
315.3
2.31
39
301
(40768806) Pleura Pathology biopsy report
13
72
1.81
1.15
1.5
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
118
1.62
1.15
1.1
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
84
682
1.25
1.14
1.3
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
208
0.57
1.12
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
208
0.57
1.12
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
208
0.57
1.12
1.2
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
127
1.58
1.12
1.1
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
207
0.58
1.10
1.2
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
53
408
1.31
1.09
3.2
3.7
mmol/l
24.8
24.1
0.98
45
373
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
339
0.67
1.09
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
65
515
1.28
1.09
2.1
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
74
1.77
1.07
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
87
716
1.23
1.06
4.6
4.5
%
0.1
0.1
0.39
23
202
(3011412) CD3 cells [#/volume] in Blood
14
82
1.72
1.05
3.4
2.0
e9/l
1.1
1.2
—
6
50
(1002224) Polysomnography panel
60
473
1.28
1.05
1.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
16
98
1.64
1.03
1.4
1.2
—
62.1
—
0
6
(40768443) Skin Pathology biopsy report
51
395
1.30
1.02
1.2
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
9
47
1.92
1.02
1.0
1.4
—
23.8
—
0
10
(3009466) Valproate [Moles/volume] in Serum or Plasma
23
155
1.49
1.01
6.0
5.8
umol/l
348.4
356.5
0.11
23
133
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
48
1.88
1.00
1.2
1.1
—
—
—
0
0
(3013512) EKG study
280
2551
1.13
1.00
4.1
3.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
29
206
1.42
0.99
3.6
4.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
175
0.57
0.98
1.2
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
61
1.81
0.98
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
61
1.81
0.98
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
61
1.81
0.98
1.4
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
92
1.64
0.97
1.9
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
63
506
1.26
0.97
1.8
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
62
1.78
0.94
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
62
1.78
0.94
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
62
1.78
0.94
1.4
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
118
0.51
0.94
2.3
2.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
27
2.23
0.93
3.0
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
28
2.15
0.91
4.0
3.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
333
1.30
0.89
2.3
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
169
0.59
0.88
1.2
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
241
0.66
0.88
1.8
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
103
1.56
0.87
1.7
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
43
1.87
0.87
1.8
3.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
168
0.59
0.87
1.2
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
30
2.01
0.87
1.5
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
6
30
2.01
0.87
1.5
1.6
pmol/l
14.1
14.0
—
6
25
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
30
2.01
0.87
1.5
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
8
44
1.82
0.86
1.3
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
32
239
1.35
0.85
1.4
2.0
iu/l
3.4
5.5
0.96
12
89
(3051593) INR in Capillary blood by Coagulation assay
6
31
1.94
0.84
8.3
13.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
104
895
1.18
0.84
2.9
3.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
111
0.54
0.83
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
33
249
1.33
0.82
1.2
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
65
1.70
0.82
1.7
1.4
—
—
—
0
0
(3019225) pH of Specimen
98
842
1.18
0.81
5.0
3.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
80
676
1.20
0.80
4.3
4.6
%
0.1
0.1
0.49
19
176
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
58
1.73
0.79
1.0
1.1
—
—
—
0
0
(4211845)
6
33
1.82
0.79
4.0
3.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
33
1.82
0.79
1.5
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
66
548
1.22
0.79
3.4
3.1
mmol/l
1.9
1.8
0.08
49
401
(21494814) CD8 cells/100 lymphocytes in Specimen
6
34
1.77
0.76
1.7
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
59
1.70
0.76
1.0
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
14
91
1.55
0.75
1.4
1.5
pmol/l
119.8
70.3
—
7
31
(3002179) Metamyelocytes/100 leukocytes in Blood
81
690
1.19
0.75
3.2
4.3
%
0.5
0.6
0.12
17
167
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
17
116
1.47
0.74
1.5
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
16
108
1.49
0.73
1.2
2.0
pg
33.6
32.4
0.45
16
108
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
92
1.53
0.72
2.9
4.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
60
1.67
0.72
3.1
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
121
1069
1.15
0.72
1.6
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
11
68
1.62
0.72
2.1
1.9
e6/l
549.2
704.9
—
6
26
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
68
573
1.20
0.71
3.3
3.1
kpa
5.1
5.1
0.41
63
540
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
40
1.75
0.71
1.3
2.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
40
1.75
0.71
1.3
2.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
54
445
1.22
0.71
1.3
1.4
iu/l
33.3
28.3
0.43
47
381
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
50
409
1.23
0.70
3.7
3.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
69
811
0.84
0.69
1.6
1.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
27
1.86
0.68
12.0
6.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
27
1.86
0.68
6.0
3.1
—
—
—
0
0
(3009343) pH of Capillary blood
67
568
1.19
0.67
3.4
3.1
ph
7.4
7.4
—
6
76
(3042631) Mycobacterium sp identified in Specimen
17
119
1.43
0.67
2.3
2.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
28
1.79
0.66
1.8
2.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
111
1.45
0.66
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
44
1.59
0.65
1.0
1.3
nmol/l
123.4
145.8
—
7
44
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
44
1.59
0.65
2.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
44
1.59
0.65
2.1
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
44
1.59
0.65
2.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
44
1.59
0.65
2.1
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
29
1.73
0.64
1.6
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
13
87
1.50
0.63
2.7
2.4
umol/l
3.7
5.4
—
7
60
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
104
920
1.14
0.62
1.8
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
30
1.67
0.61
1.2
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
30
1.67
0.61
1.6
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
106
941
1.14
0.61
1.3
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
905
8876
1.09
0.58
17.5
13.5
%
40.2
40.3
0.23
662
6741
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
184
1.31
0.58
4.0
4.0
%
53.7
56.9
0.57
24
184
(3034891) Synovial lining cells/100 cells in Synovial fluid
6
35
1.72
0.57
2.7
1.3
%
—
5.3
—
0
10
(3001019) Free T4 and TSH panel - Serum or Plasma
49
581
0.84
0.57
1.5
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
74
646
1.16
0.55
1.1
1.2
iu/ml
161.0
147.1
0.09
39
259
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
60
1.50
0.54
1.1
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
9
61
1.48
0.53
1.7
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
22
169
1.31
0.53
1.5
2.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
62
1.46
0.53
3.8
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
34
278
1.23
0.51
1.2
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
17
126
1.35
0.51
1.4
1.4
nmol/l
0.6
0.6
0.13
17
117
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
191
0.73
0.51
1.5
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
37
306
1.22
0.51
2.1
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
36
297
1.22
0.50
1.4
1.2
miu/ml
241.7
234.2
0.05
18
134
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
9
65
1.39
0.50
12.7
11.2
mmol/l
0.5
0.6
—
9
59
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
41
1.47
0.50
1.8
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
13
179
0.72
0.50
1.6
1.5
u/ml
120.0
129.0
—
6
36
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
27
216
1.26
0.49
2.0
2.1
ug/min
41.9
90.4
0.78
18
127
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
110
1.37
0.49
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
23
181
1.28
0.48
1.2
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
181
1.28
0.48
3.7
3.6
e9/l
4.0
4.2
0.18
23
181
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
47
1.49
0.47
1.0
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
153
0.72
0.45
1.2
1.0
u/ml
0.0
2.1
—
5
66
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
156
1.29
0.45
1.5
1.2
u/ml
7.0
5.2
—
8
52
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
104
1.35
0.43
1.4
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
104
1.35
0.43
1.4
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
32
1.56
0.42
6.8
2.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
32
1.56
0.42
2.4
3.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
140
1.29
0.42
1.1
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
105
1.34
0.41
1.4
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
17
0.00
0.40
0.0
3.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
88
1.37
0.40
1.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
18
0.00
0.40
0.0
3.2
—
4394.3
—
0
18
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
30
251
1.20
0.39
2.7
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
2.6
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
2.6
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
35
1.43
0.39
2.6
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
35
1.43
0.39
1.6
2.5
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.4
2.5
umol/l
72.2
49.0
—
5
27
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
106
1.32
0.39
1.3
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
106
1.32
0.39
1.4
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
151
1.26
0.38
1.1
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
107
1.31
0.37
1.4
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
107
1.31
0.37
1.4
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
37
1.35
0.37
1.8
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
36
417
0.86
0.36
1.6
1.8
mg/l
2.7
4.2
0.46
30
292
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
78
0.64
0.35
1.2
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
9
123
0.73
0.35
1.2
1.9
—
1808.0
—
0
5
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
110
1018
1.09
0.35
1.9
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
31
362
0.85
0.35
1.5
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
283
1.17
0.34
2.5
2.3
u/l
10293.8
2296.2
0.48
15
116
(3039443) Prostate specific Ag panel - Serum or Plasma
19
232
0.82
0.34
2.1
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
100
1.30
0.33
1.2
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
89
0.67
0.33
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
252
0.83
0.32
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
54
1.30
0.30
1.3
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
75
1.34
0.30
1.6
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
84
1.31
0.30
1.2
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
166
1.21
0.30
4.0
3.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
57
1.23
0.29
1.3
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
19
158
1.21
0.28
1.5
1.2
u/ml
3.0
4.0
—
6
45
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
161
0.81
0.27
1.2
1.0
u/ml
0.4
6.7
—
7
85
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
204
0.83
0.27
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
139
0.79
0.27
1.4
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
105
1118
0.93
0.26
1.4
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
72
1.25
0.25
1.1
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
73
1.23
0.25
1.2
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
14
170
0.82
0.25
1.6
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
23
198
1.16
0.24
3.1
3.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
191
0.84
0.24
1.3
1.2
u/ml
252.5
249.6
—
8
119
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
133
1.21
0.24
1.3
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
84
0.71
0.24
1.7
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
256
1.14
0.23
2.6
2.9
u/ml
0.4
0.3
0.23
18
141
(3002256) Pathology report gross observation
109
1151
0.94
0.22
1.2
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
17
144
1.18
0.22
1.4
1.7
g/l
0.6
0.8
0.54
11
108
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
42
1.19
0.21
1.6
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
9.0
—
0
5
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
3.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
43
1.16
0.21
1.0
1.1
iu/ml
172.8
187.7
—
5
43
(4062490)
11
89
1.24
0.21
1.3
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
89
1.24
0.21
1.1
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
187
0.85
0.20
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
187
0.85
0.20
1.2
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.0
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
74
695
1.07
0.19
1.4
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.0
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
203
1.14
0.19
1.6
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
53
1.13
0.18
1.3
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
338
1.10
0.18
1.7
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
58
1.21
0.18
3.3
7.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
100
1.20
0.18
1.2
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.18
1.0
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
31
281
1.11
0.17
1.6
1.7
iu/ml
0.0
0.1
—
9
40
(44813793)
7
61
1.15
0.17
1.1
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
110
1.18
0.17
1.5
1.3
nmol/l
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
82
778
1.06
0.17
4.1
3.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
120
1.17
0.16
1.3
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
15
130
1.16
0.15
1.0
1.1
—
—
—
0
0
(4146454)
9
82
1.10
0.15
3.9
2.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
84
1.19
0.14
3.7
1.3
—
—
—
0
0
(4281824)
8
100
0.80
0.13
1.1
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
94
1.17
0.13
1.1
1.1
—
—
—
0
0
(4306422)
17
152
1.12
0.12
1.1
1.2
—
—
—
0
0
(4035726)
78
813
0.96
0.12
1.3
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
143
1.12
0.11
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
143
1.12
0.11
1.2
1.2
—
—
—
0
0
(3010421) pH of Blood
26
240
1.09
0.11
3.7
4.1
ph
7.4
7.4
0.39
20
193
(3023419) Bacteria identified in Sputum by Culture
12
105
1.14
0.11
1.3
2.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
28
260
1.08
0.11
1.3
1.2
—
1162.2
—
0
9
(40768793) Breast Pathology biopsy report
21
229
0.92
0.11
1.7
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
114
0.88
0.09
2.0
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
370
3744
0.98
0.09
2.1
2.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(4268621)
12
107
1.12
0.08
2.4
2.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
181
1777
1.02
0.08
2.7
2.8
ug/l
0.6
0.7
2.02
118
1103
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
185
1.08
0.08
1.5
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
64
0.78
0.08
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
67
1.05
0.08
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
74
1.08
0.07
2.3
1.9
%
12.1
11.4
—
8
74
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
73
708
1.03
0.07
6.5
3.8
mmol/l
1.2
1.2
0.41
67
614
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
151
1482
1.02
0.07
1.5
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
10
89
1.12
0.07
2.1
1.4
ug/l
13.6
2.4
—
10
75
(3012501) Base excess in Blood by calculation
21
197
1.07
0.06
4.0
4.5
mmol/l
1.8
2.4
0.74
16
126
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
17
158
1.08
0.06
1.9
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
159
1.07
0.05
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
159
1.07
0.05
1.1
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
110
0.91
0.05
2.0
1.9
%
91.0
89.6
—
10
110
(3003694) ABO and Rh group [Type] in Blood
262
2596
1.01
0.05
1.3
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
140
0.93
0.04
1.3
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
101
1.09
0.04
1.1
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
109
1104
0.99
0.03
4.6
4.2
%
32.2
31.5
0.31
82
761
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
302
1.03
0.02
1.3
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
117
0.94
0.01
1.8
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
16
153
1.05
0.01
1.2
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
26
254
1.02
0.00
1.3
1.2
titre
66.7
100.0
—
6
22
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
154
0.97
0.00
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
186
1.02
0.00
1.6
2.5
%
14.9
16.6
0.64
11
102
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
141
0.99
0.00
1.1
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
30
301
1.00
0.00
1.4
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
117
1.03
0.00
1.1
1.0
u/ml
1.0
4.3
—
5
47
(3024928) Oxygen saturation in Venous blood
19
195
0.97
0.00
2.1
3.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
13
125
1.04
0.00
1.3
1.3
mmol/l
7.8
7.4
—
8
90
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
57
0.88
0.00
2.4
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
85
0.94
0.00
1.1
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
321.0
—
0
5
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
160
1.00
0.00
1.1
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
1.9
—
1.5
—
0
7
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
34.3
—
0
6
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.6
—
0
5
(3001556) Androgen free Index in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
8.3
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
37.2
—
0
5
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
9
0.00
0.00
0.0
14.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
66
0.91
0.00
2.3
2.4
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
15.3
—
0
6
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
23.0
—
0
5
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
79
0.89
0.00
1.6
1.5
g/l
1.0
1.0
—
7
79
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
5.4
—
0
6
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
66
0.91
0.00
1.5
1.6
mmol/l
7.1
6.4
—
6
40
(21494434) Karyotype in Bone marrow
8
83
0.96
0.00
1.3
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MONONPOTHUS and mortality.

Females

Parameter HR [95% CI] p-value
G6_MONONPOTHUS 1.214 [1.06, 1.39] 0.004
Birth year 0.999 [0.99, 1.01] 0.8

During the follow-up period (1.1.1998 — 31.12.2019), 397 out of 3043 females with G6_MONONPOTHUS died.

Males

Parameter HR [95% CI] p-value
G6_MONONPOTHUS 1.422 [1.24, 1.63] < 0.001
Birth year 0.987 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 468 out of 3225 males with G6_MONONPOTHUS died.

Mortality risk

Mortality risk for people of age

years, who have G6_MONONPOTHUS.

N-year risk Females Males
1 0.087% 0.276%
5 0.669% 1.607%
10 1.97% 3.865%
15 4.024% 7.496%
20 7.219% 12.516%

Relationships between endpoints

↥

Index endpoint: G6_MONONPOTHUS – Other and unspecified mononeuropathies of upper limb

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data